[1] Newburger JW, Takahashi M, Burns JC. Kawasaki disease[J]. J Am Coll Cardiol, 2016, 67(14):1738-1749.
[2] McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease:a scientifc statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135(17):e927-e999.
[3] Dergun M, Kao A, Hauger SB, et al. Familial occurrence of Kawasaki syndrome in North America[J]. Arch Pediatr Adolesc Med, 2005, 159(9):876-881.
[4] Harnden A, Mayon-White R, Perera R, et al. Kawasaki disease in England:ethnicity, deprivation, and respiratory pathogens[J]. Pediatr Infect Dis J, 2009, 28(1):21-24.
[5] Holman RC, Christensen KY, Belay ED, et al. Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii[J]. Hawaii Med J, 2010, 69(8):194-197.
[6] Uehara R, Yashiro M, Nakamura Y, et al. Clinical features of patients with Kawasaki disease whose parents had the same disease[J]. Arch Pediatr Adolesc Med, 2004, 158(12):1166-1169.
[7] Sudo D, Nakamura Y. Nationwide surveys show that the incidence of recurrent Kawasaki disease in Japan has hardly changed over the last 30 years[J]. Acta Paediatr, 2017, 106(5):796-800.
[8] Zhu FH, Ang JY. The clinical diagnosis and management of Kawasaki disease:a review and update[J]. Curr Infect Dis Rep, 2016, 18(10):32.
[9] Yoon KL. Update of genetic susceptibility in patients with Kawasaki disease[J]. Korean J Pediatr, 2015, 58(3):84-88.
[10] Uehara R, Yashiro M, Nakamura Y, et al. Parents with a history of Kawasaki disease whose child also had the same disease[J]. Pediatr Int, 2011, 53(4):511-514.
[11] Gordon CT, Jimenez-Fernandez S, Daniels LB, et al. Pregnancy in women with a history of Kawasaki disease:management and outcomes[J]. BJOG, 2014, 121(11):1431-1438.
[12] Mori M, Miyamae T, Kurosawa R, et al. Two-generation Kawasaki disease:mother and daughter[J]. J Pediatr, 2001, 139(5):754-756.
[13] Bruckheimer E, Bulbul Z, McCarthy P, et al. Images in cardiovascular medicine. Kawasaki disease:coronary aneurysms in mother and son[J]. Circulation, 1998, 97(4):410-411.
[14] Caquard M, Parlier G, Siret D. Family observation of Kawasaki disease:2 cases in sister and brother[J]. Arch Pediatr, 2006, 13(5):453-455.
[15] Türel Ö, Bornaun H, Hatipoglu N, et al. Kawasaki disease in dizygotic twins in Turkey[J]. J Rheumatol, 2011, 38(8):1812-1813.
[16] Kraszewska-Glomba B, Kuchar E, Szenborn L. Three episodes of Kawasaki disease including one after the Pneumo 23 vaccine in a child with a family history of Kawasaki disease[J]. J Formos Med Assoc, 2016, 115(10):885-886.
[17] 高天霁. 姑表兄弟同患川崎病2例报道[J]. 中国当代儿科杂志, 2012, 14(4):314-315.
[18] 张谦慎, 董国庆. 同胞共患川崎病三例[J]. 中国优生与遗传杂志, 2007, 15(2):109.
[19] 张俊红, 徐华, 张蕾. 双胞胎兄弟同患川崎病[J]. 空军总医院学报, 2003, 19(2):96.
[20] 贺传芬. 一家姐弟俩同患川崎病[J]. 武汉医学杂志, 1996, 20(3):176.
[21] Makino N, Nakamura Y, Yashiro M, et al. Epidemiological observations of Kawasaki disease in Japan, 2013-2014[J]. Pediatr Int, 2018. doi:10.1111/ped.13544.[Epub ahead of print].
[22] Du ZD, Zhao D, Du J, et al. Epidemiologic study on Kawasaki disease in Beijing from 2000 through 2004[J]. Pediatr Infect Dis J, 2007, 26(5):449-451.
[23] Chen JJ, Ma XJ, Liu F, et al. Epidemiologic features of Kawasaki disease in Shanghai from 2008 through 2012[J]. Pediatr Infect Dis J, 2016, 35(1):7-12.
[24] Fujita Y, Nakamura Y, Sakata K, et al. Kawasaki disease in families[J]. Pediatrics, 1989, 84(4):666-669.
[25] Nagao Y, Urabe C, Nakamura H, et al. Predicting the characteristics of the aetiological agent for Kawasaki disease from other paediatric infectious diseases in Japan[J]. Epidemiol Infect, 2016, 144(3):478-492.
[26] Chang LY, Lu CY, Shao PL, et al. Viral infections associated with Kawasaki disease[J]. J Formos Med Assoc, 2014, 113(3):148-154.
[27] Tsai HC, Chang LY, Lu CY, et al. Transmission of acute infectious illness among cases of Kawasaki disease and their household members[J]. J Formos Med Assoc, 2015, 114(1):72-76.
[28] Yen TY, Lin HC, Hsu YL, et al. Possible infectious etiology among Kawasaki disease patients and their families[J]. J Formos Med Assoc, 2017, 116(3):213.
[29] Hara T, Nakashima Y, Sakai Y, et al. Kawasaki disease:a matter of innate immunity[J]. Clin Exp Immunol, 2016, 186(2):134-143.
[30] Wang CL, Wu YT, Liu CA, et al. Expression of CD40 ligand on CD4⁺ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease[J]. Pediatrics, 2003, 111(2):E140-E147.
[31] Onouchi Y, Onoue S, Tamari M, et al. CD40 ligand gene and Kawasaki disease[J]. Eur J Hum Genet, 2004, 12(12):1062-1068.
[32] Wang Y, Wang W, Gong F, et al. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profles in patients with Kawasaki disease[J]. Arthritis Rheum, 2013, 65(3):805-814.
[33] Shrestha S, Wiener HW, Aissani B, et al. Imputation of class I and Ⅱ HLA loci using high-density SNPs from ImmunoChip and their associations with Kawasaki disease in family-based study[J]. Int J Immunogenet, 2015, 42(3):140-146.
[34] Xie X, Shi X, Liu M. The roles of genetic factors in Kawasaki disease:a systematic review and meta-analysis of genetic association studies[J]. Pediatr Cardiol, 2018, 39(2):207-225.
[35] Kuo HC, Hsu YW, Lo MH, et al. Single-nucleotide polymorphism rs7251246 in ITPKC is associated with susceptibility and coronary artery lesions in Kawasaki disease[J]. PLoS One, 2014, 9(3):e91118.
[36] Onouchi Y, Suzuki Y, Suzuki H, et al. ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease[J]. Pharmacogenomics J, 2013, 13(1):52-59.
[37] Chang CJ, Kuo HC, Chang JS, et al. Replication and metaanalysis of GWAS identified susceptibility loci in Kawasaki disease confrm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility[J]. PLoS One, 2013, 8(8):e72037.
[38] 程首超, 程衍杨, 吴金龙. CD40基因多态性与川崎病及其冠状动脉损伤的相关性研究[J]. 中国当代儿科杂志, 2014, 16(10):1025-1028.
[39] Lin L, Wang SY, Yang SB, et al. Association between the FCGR2A gene H131R polymorphism and risk of Kawasaki disease:a meta-analysis[J]. Genet Mol Res, 2015, 14(2):6256-6264.
[40] Kuo HC, Chang JC, Kuo HC, et al. Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array[J]. Arthritis Rheumatol, 2015, 67(3):828-836.
[41] Lee YH, Bae SC, Choi SJ, et al. Associations between the functional CD40 rs4810485 G/T polymorphism and susceptibility to rheumatoid arthritis and systemic lupus erythematosus:a meta-analysis[J]. Lupus, 2015, 24(11):1177-1183.
[42] Pamuk ON, Tozkir H, Uyanik MS, et al. PECAM-1 gene polymorphisms and soluble PECAM-1 level in rheumatoid arthritis and systemic lupus erythematosus patients:any link with clinical atherosclerotic events?[J]. Clin Rheumatol, 2014, 33(12):1737-1743.
[43] Onouchi Y. The genetics of Kawasaki disease[J]. Int J Rheum Dis, 2018, 21(1):26-30.
[44] Onouchi Y, Suzuki Y, Suzuki H, et al. ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease[J]. Pharmacogenomics J, 2013, 13(1):52-59.
[45] Labuda LA, de Jong SE, Meurs L, et al. Differences in innate cytokine responses between European and African children[J]. PLoS One, 2014, 9(4):e95241.
[46] Kim J, Shimizu C, Kingsmore SF, et al. Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility[J]. PLoS One, 2017, 12(2):e170977.